China Infectious Disease Treatment Market Growth of 5.01% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: GSK, Johnson & Johnson, Pfizer, Merck - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Infectious Disease Treatment Market in China 2016-2020" report to their offering.

The infectious disease treatment market in China is forecast to grow at a CAGR of 5.01% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the infectious disease treatment market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat infectious diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The report, Infectious Disease Treatment Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Questions Answered:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

  • F. Hoffmann-La Roche
  • Gilead Sciences
  • GSK
  • Johnson & Johnson
  • Merck
  • Pfizer
  • Achaogen
  • Actelion
  • Adenovir Pharma
  • AstraZeneca
  • Bayer
  • Biocryst
  • Celsus Therapeutics
  • Cempra
  • Eleven Biotherapeutics
  • Exoxemis
  • Ferrer International
  • Griffin Discoveries
  • Hexi

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: China - An overview

PART 06: Opportunities for global and local vendors

PART 07: Pipeline analysis

PART 08: Market landscape

PART 09: Market segmentation by application

PART 10: Antibacterial drugs market in China

PART 11: Antiviral drugs market in China

PART 12: Antifungal drugs market in China

PART 13: Antiparasitic drugs market in China

PART 14: Market drivers

PART 15: Impact of drivers

PART 16: Market challenges

PART 17: Impact of drivers and challenges

PART 18: Market trends

PART 19: Vendor landscape

PART 20: Appendix

PART 21: About the Author

For more information visit http://www.researchandmarkets.com/research/hpr22c/infectious.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs